Skip to main navigation Skip to search Skip to main content

A Phase 2, Double-blind, Randomized, Placebo-controlled, 4-arm Study to Investigate Symptoms, Function, Health-Related Quality of Life, and Safety, With Repeated Subcutaneous Administration of Ponsegromab Versus Placebo in Adult Participants With Heart Failure”, and with brief title: “A Phase 2 Study of the Effects of Ponsegromab on Health-Related Quality of Life and Safety in Patients With Heart Failure (GARDEN-TIMI 74)

  • Kaye, David (Primary Chief Investigator (PCI))
  • Jayasinghe, Satyajit Rohan (Chief Investigator (CI))
  • Kumarasinghe, Gayathri (Chief Investigator (CI))
  • Stokes, Michael Benjamin (Chief Investigator (CI))
  • Arstall, Margaret (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date13/12/22 → 7/11/24

Keywords

  • clinical trial
  • heart failure
  • Ponsegromab
  • cardiology

Clinical Trial Phase

  • Phase II